Journal
TRENDS IN BIOCHEMICAL SCIENCES
Volume 33, Issue 10, Pages 474-481Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2008.06.008
Keywords
-
Categories
Funding
- National Institutes of Health [R01 CA120185]
- Sol Goldman Pancreatic Cancer Research Center
- Medical Scientist Training Program at Johns Hopkins
- Rita Allen Foundation Scholar
- Leukemia and Lymphoma Society Scholar
- NATIONAL CANCER INSTITUTE [R01CA120185] Funding Source: NIH RePORTER
Ask authors/readers for more resources
MicroRNAs (miRNAs) have attracted considerable attention because of their important roles in development, normal physiology, and disease states including cancer. Recent studies have identified specific miRNAs that regulate the cell cycle and have documented that the loss or gain of miRNA-mediated cell-cycle control contributes to malignancy. miRNAs regulate classic cell-cycle control pathways by directly targeting proteins such as E2F transcription factors, cyclin-dependent kinases (Cdks), cyclins and Cdk inhibitors. Moreover, from recent findings, it has been suggested that miRNAs themselves might be subject to cell-cycle dependent regulation. Together, these observations indicate that the reciprocal control of RNA silencing and the metazoan cell cycle impacts cellular behavior and disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available